• Early A, Pabla S, Conroy JM, Nesline MK, Glenn S, Papanicolau-Sengos A, Burgher B, Giamo V, Andreas J, DePietro P, Lenzo F,Wang Y, Morrison C. Immune Subsets by GI Tumor Type. Society for Immunotherapy of Cancer 33rd Annual Meeting. November 9, 2018 
• Dhakal A, Early A, Matthews C, Levine E, Zhang F, Young J, Takabe K, Salerno K, Opyrchal M, Edge S, Khoury T, O’Connor T. Outcome of palbociclib based therapy in hormone receptor positive metastatic breast cancer patients after treatment with everolimus. Clin Breast Cancer published online 04/28/2018.
• Masqood A, Early AP, Khoury T, Kumar P. Pananicolau-Sengos A. Neuroendocrine carcinoma of the breast with endobronchial metastases and syndrome of inappropriate anti-diuretic hormone secretion. Clin Breast Cancer 17(5):e229-32, 2017 
• Dhakal A, Matthews C, Zhang F, Levine EG, Edge SB, Salerno KE, O”Connor T, Early AP, Khoury T, Takabe K, Young JS, Opyrchal M. Outcome of palbociclib based therapy in hormone receptor positive metastatic breast cancer pateints after treatment with everolimus. Abstract #1054. Poster presentation 2017 ASCO Annual Meeting. June 4, 2017. J Clin Oncol 35(15 suppl):1054,2017
• Early AP and the Consensus Committee of the American Society of Breast Disease: Commentary on Surveillance Imaging of the Reconstructed Breast. ASBD Advisor. Vol. 1. Winter/Spring 2013.
• Pruthi S, Simon J, Early AP. A Current Overview of the Management of Urogenital Atrophy in Women with Breast Cancer. The Breast Journal 17(4):403-408, 2011.
• Early AP and the Consensus Committee of the American Society of Breast Disease: Consensus Statement on the use of Aromatase Inhibitors in Perimenopausal Women with Breast Cancer. ASBD Advisor. Vol. 1. Winter/Spring 2011.
• Early AP and the Consensus Committee of the American Society of Breast Disease: The Use of Adjuvant Trastuzumab in Women with HER2-Positive, Operable Breast Cancer. Available at: www.asbd.org. Released November 10, 2006.
• Early AP, et al. for the Subcommittee on Screening of High Risk Women: Policy Statement on the use of Magnetic Resonance Imaging to Screen Women at High Risk of Breast Cancer. Available at: www.asbd.org. and www.guideline.gov. Released June 28, 2004.

Dr. Early has given presentations at national and regional symposia including:

• Early AP: Clinical Impact of Genomic Sequencing in Cancer of the Lung. Louisiana State University School of Medicine, New Orleans, LA, November 18, 2016.
• Early AP: Immunotherapy and Targeted Therapy for Cancer of the Lung. City-Wide Grand Rounds Jacobs School of Medicine and Biomedical Sciences, September 14, 2017.
• Early AP: Management of the Axilla while Minimizing Morbidity-The Roles of Surgery, Radiation, Systemic Therapy & Observation. National Consortium of Breast Centers Annual Interdisciplinary Breast Center Conference, Las Vegas, NV, March 14, 2015.
• Early AP: Plenary Session. The Obesity Epidemic: Impact on Breast Cancer and Survivorship. National Consortium of Breast Centers Annual Interdisciplinary Breast Center Conference, Las Vegas, NV, March 14, 2015.
• Early AP: AP107 The Impact of Pathology Practice on Outcome of Patients with Ductal Carcinoma In Situ (DCIS). College of American Pathology Annual Meeting 2013, Orlando, FL, October 13, 2013.
• Early AP: How to Integrate Axillary Surgical Staging Data into Decision Making for Medical Oncologists. American Society of Breast Disease 36th Annual Symposium, Dallas, TX, April 13, 2012.